Category Archives: Biotech

A synthetic biology company bites the dust

By Deepak Singh | Published: April 6, 2009
I’ve been busy, so missed out on Keith’s blog posts on the subject of Codon shutting down it’s doors. It’s a sign of the times. Very difficult to be a company looking for financing these days, but I wonder if it has anything to say about the maturity of synthetic biology as a [...]
Also posted in Industry | Leave a comment

Still waiting for that biosciences startup school

By Deepak Singh | Published: March 29, 2009
About this time last year I wondered if we would ever see a biosciences startup school. As I read about Capital Factory, I am still wondering. In Boston, San Diego, and San Francisco, especially with the University side as active as it is, there should be sufficient mass to make this happen.
Also posted in Business, Innovation, Life Science | 4 Comments

Industry watching: Biotech finally makes a profit

By Deepak Singh | Published: March 21, 2009
Image by Getty Images via Daylife In Science Business, a book that I am going to revisit to do a better job of talking about innovation in the biotech industry, Gary Pisano talks about the lack of profitability in the biotech industry (assuming the formation of Genentech as the day the industry was formed). He [...]
Also posted in Industry Watching, Innovation | 4 Comments

Innovation, biotech, software, etc

By Deepak Singh | Published: March 10, 2009
Image via Wikipedia Chris asked me to talk about biotech and innovation, so I don’t really have a choice. This is just a preamble, and more will come down the road. Over the years, I have talked a lot about innovation, especially in the life sciences. Earlier today, I started a bit of [...]
Also posted in Drug Development, Innovation | Leave a comment

Industry watching: Next generation biopharma

By Deepak Singh | Published: September 12, 2008
We wonder whether the traditionally do-it-all, own-it-all from every part of the value chain is sustainable. It’s certainly a risky and costly model That quote comes from Elliot Sigal, the CSO at Bristol Myers-Squibb. Bio-IT World has an article where it talks about Sigal’s proposal to make BMS a next generation biopharma company. Hmmm, [...]
Also posted in Industry Watching, Pharma | 2 Comments

  • Archives